Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes
Author(s) -
Ross Nortley,
Nils Korte,
Pablo Izquierdo,
Chanawee Hirunpattarasilp,
Anusha Mishra,
Zane Jaunmuktane,
Vasiliki Kyrargyri,
Thomas Pfeiffer,
Lila Khennouf,
Christian Madry,
Hui Gong,
Angela Richard-Loendt,
Wenhui Huang,
Takashi Saito,
Takaomi C. Saido,
Sebastian Brandner,
Huma Sethi,
David Attwell
Publication year - 2019
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aav9518
Subject(s) - pericyte , neurodegeneration , arteriole , cerebral amyloid angiopathy , cognitive decline , constriction , alzheimer's disease , neuroscience , biology , human brain , microcirculation , microbiology and biotechnology , disease , pathology , chemistry , medicine , endocrinology , in vitro , biochemistry , endothelial stem cell , dementia
Cerebral blood flow is reduced early in the onset of Alzheimer's disease (AD). Because most of the vascular resistance within the brain is in capillaries, this could reflect dysfunction of contractile pericytes on capillary walls. We used live and rapidly fixed biopsied human tissue to establish disease relevance, and rodent experiments to define mechanism. We found that in humans with cognitive decline, amyloid β (Aβ) constricts brain capillaries at pericyte locations. This was caused by Aβ generating reactive oxygen species, which evoked the release of endothelin-1 (ET) that activated pericyte ET A receptors. Capillary, but not arteriole, constriction also occurred in vivo in a mouse model of AD. Thus, inhibiting the capillary constriction caused by Aβ could potentially reduce energy lack and neurodegeneration in AD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom